Psychotherapy authorisation with Adeslas: sessions, blocks and the 30-day rule
What we know about Adeslas in psychotherapy
Adeslas publishes a general 30-day calendar rule for most authorisations from the date indicated in the request. Specific Adeslas behaviour in psychotherapy, the number of authorisable sessions per block and renewal conditions are not fully published and depend on the centre agreement. The clinic must verify its real Adeslas pattern rather than assume general rules.
The 30-day rule applied to session blocks
A typical psychotherapy block schedules weekly or biweekly sessions across several weeks. The general 30-day calendar rule can leave the block partially out of window if the first sessions happen at month-end and the last ones fall in the next month. An admin only looking at the initial authorisation without counting sessions loses track of the real block end date.
Documented renewal and clinical cost of interruption
Adeslas psychotherapy block renewal is built on the professional evolution report, not the original request. When renewal arrives late, intermediate sessions are delivered without valid authorisation and the invoice is rejected. Beyond the economic cost, interrupting mid-therapy carries a hard-to-quantify but real clinical cost. Per-session and per-block traceability stops being administrative and enters the clinical domain.
How SaludComply approaches it
SaludComply links every block to the patient, the treating professional and a delivered-sessions counter. The queue combines the 30-day rule with the real session pace to alert before the block expires or runs out, whichever comes first. The agent prepares renewal with the evolution report and the clinic admin approves before submitting to the Adeslas portal. Therapeutic continuity gains reliability.
Verified sources
- Adeslas — Autorizaciones — fuente oficial sobre proceso y caducidad
- SaludComply — diagnóstico de autorizaciones — diagnóstico de fuga por autorizaciones
Related pages
Calculate revenue lost to authorisations
Use the SaludComply authorisation diagnostic to estimate monthly loss, recoverable range and operational complexity. No patient data required.